Skip to Main Content

Paper Details

Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role?
Surgery
1
2021
Author NameAffiliation
Christopher L CorlessOregon Health & Science University
  • 1 - 1

Datasets

Release 1.2